Lumexa Imaging(NASDAQ) LMRI

Lumexa Imaging Holdings, Inc. operates medical centers that perform diagnostic scans. These facilities help patients get fast and affordable health tests. Doctors use these services to identify illnesses and plan treatments.

Scanning the Product Menu

• Outpatient Imaging Centers: Medical facilities that perform scans such as MRI, CT, and PET procedures; accounted for $143.7 million in net patient service revenue for the three months ended June 30, 2026.
• Professional Services: Radiologists who provide interpretations for imaging studies performed at hospitals or joint ventures; generated $64.3 million in net patient service revenue for the three months ended June 30, 2026.
• Management Services: Administrative support and operational oversight for non-consolidated imaging centers; provided $51.7 million in related-party management fee revenue for the three months ended June 30, 2026.

Growing the Clinical Footprint

• Added 11 consolidated de novo centers from 2024 to 2026 to increase service capacity.
• Acquired two joint venture centers during the six-month period ended June 30, 2026.
• Refinanced a credit facility in Dec. 2025 to establish a new $825.0 million term loan maturing in Dec. 2032.
• Began using third-party artificial intelligence tools to improve scan efficiency and patient scheduling.

Why Lumexa Stands Out

Lumexa operates 192 centers across 14 states, making it the second largest outpatient imaging provider in the nation. The company maintains over 600 payor contracts to ensure diverse revenue sources and sustainable reimbursement rates.

The Financial Scorecard

• Total revenue was $264.2 million for the three-month period ended June 30, 2026, up 5.1% year over year.
• Net income was $2.7 million for the three months ended June 30, 2026, compared to a $7.2 million loss for the same period in 2025.
• Interest expense decreased 46.1% to $16.2 million for the three months ended June 30, 2026, following a debt refinancing.
• Net cash provided by operating activities hit $35.7 million for the six months ended June 30, 2026.
• The company had a market capitalization of $1.2 billion according to recent market data.

Bottom Line

Lumexa has transitioned from a 2018 startup to one of the largest national providers of outpatient diagnostic imaging. Its integrated model combines physical centers with professional interpretation services to manage high patient volumes across multiple states.